戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  in potency of 2-10-fold compared to that of tachyplesin.
2 nt for the membrane-disruptive activities of tachyplesins.
3  was examined in two peptide series based on tachyplesin, a known beta-stranded antimicrobial peptide
4 4 dendrimer are comparable to protegrins and tachyplesins, a family of potent antimicrobials containi
5                  Finally, the combination of tachyplesin and human serum markedly inhibited the proli
6 y to identify a protein that interacted with tachyplesin and isolated a sequence corresponding to the
7                      Treatment of cells with tachyplesin and serum increased in membrane permeability
8 en together, these observations suggest that tachyplesin binds to both hyaluronan on the cell surface
9 ed the charge and hydrophobic amino acids of tachyplesin, but contained zero to four covalent constra
10 e charges resembling those in protegrins and tachyplesins, but were less cytotoxic.
11 nt constraints, included a cyclic tricystine tachyplesin (ccTP 1).
12                   In this study, a synthetic tachyplesin conjugated to the integrin homing domain RGD
13                                       Cyclic tachyplesins consisting of 14 and 18 amino acids are con
14 ting showed that treatment of cells with RGD-tachyplesin could activate caspase 9, caspase 8, and cas
15 O-PRO-1, and FITC-dextran indicated that RGD-tachyplesin could induce apoptosis in both tumor and end
16   The in vivo studies indicated that the RGD-tachyplesin could inhibit the growth of tumors on the ch
17 e disulfide-stabilized antimicrobial peptide tachyplesin I (TP) in lipid bilayers are determined by s
18  role of amphipathicity using an analogue of tachyplesin I (TP-I), CDT (KWFRVYRGIYRRR-NH(2)), in whic
19 an NMR structural investigation of wild-type tachyplesin I and three linear derivatives (denoted TPY4
20  also determined the structures of wild-type tachyplesin I and TPY4 in the presence of dodecylphospho
21 elle and aqueous solution for both wild-type tachyplesin I and TPY4 reveals two requirements for high
22 cribe the chemical synthesis of a variant of tachyplesin I in which its two disulfide bonds are in a
23                                              Tachyplesin I is a 17-residue peptide isolated from the
24                                              Tachyplesin I is a cyclic beta-sheet antimicrobial pepti
25                The four cysteine residues in tachyplesin I play a structural role in imparting amphip
26                    Our substrate is based on tachyplesin I, a 17-mer peptide that folds into a beta h
27                     For a beta-sheet peptide tachyplesin I, which may be quite ordered at the solid/l
28 rization of the disulfide bonds in nonnative tachyplesin I.
29                                              Tachyplesin-I (TP-I) is a 17-residue beta-hairpin antimi
30       When TSU tumor cells were treated with tachyplesin in the presence of serum, activated C4b and
31         The in vitro results showed that RGD-tachyplesin inhibited the proliferation of both cultured
32                                              Tachyplesin is a small, cationic peptide that possesses
33                                              Tachyplesin is an antimicrobial peptide present in leuko
34                                              Tachyplesin seemed to activate the classic complement ca
35 eric cystine-stabilized beta-strand (CSbeta) tachyplesin (TP) in a panel of 10 test organisms.
36 rophobic amino acid) found in protegrins and tachyplesins whereas the octapeptide R8 (RLYRKVYG) consi

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。